| Karen Ruth Weyman, OTR, L | |
|
9660 S 1300 E, Sandy, UT 84094 | |
| (801) 501-2153 | |
| Not Available |
| Full Name | Karen Ruth Weyman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 9660 S 1300 E, Sandy, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013138999 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 332495-4201 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Ruth Weyman, OTR, L 9660 S 1300 E, Sandy, UT 84094 Ph: (801) 501-2153 | Karen Ruth Weyman, OTR, L 9660 S 1300 E, Sandy, UT 84094 Ph: (801) 501-2153 |
News Archive
Three months after health reform was enacted, state leaders are beginning to make decisions about implementing the new law, Politico reports: "With the messy politics of health reform, the burden of balancing state budgets and the goal of expanding health coverage, lawmakers at the state level have had mixed reactions."
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies.
FDA & USDA announced today they have approved SALMONELEX as a "GRAS" (Generally Recognized as Safe) food processing aid against Salmonella. The new product consists of natural phages against Salmonella and is produced by Micreos of The Netherlands. The company confirms that industrial scale projects with US poultry processors will start in January 2014.
While overall emergency department use in Massachusetts continues to rise, the number of low-severity visits dropped slightly since the implementation of the state's health care reform law, according to an Annals of Emergency Medicine study published online.
› Verified 2 days ago
Kimberlee Cristina Voss, MS OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 630 E Pioneer Ave, Sandy, UT 84070 Phone: 586-208-3188 | |
Eric Merizon, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Albion Village Way, Sandy, UT 84070 Phone: 801-619-3670 | |
Ella Gilda Fitzmayer, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9361 S 300 E, Sandy, UT 84070 Phone: 801-826-5000 | |
Kelcey Ovard Murdoch, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 870 E 9400 S Ste 112, Sandy, UT 84094 Phone: 801-571-3081 | |
Nellie Alexandra Muscarello, M.S., OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 90 Albion Village Way, Sandy, UT 84070 Phone: 801-619-3670 Fax: 801-619-3679 | |
Danni Miller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 870 E 9400 S, 112, Sandy, UT 84094 Phone: 801-571-3081 Fax: 801-571-4002 |